Edgemode Inc (WDDN) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Edgemode Inc   (WDDN)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Edgemode Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Edgemode Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Edgemode Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -21 -9 -9 -25 -14
Return On Equity (TTM) - - - - -
WDDN's Total Ranking # # # # #
Equity (TTM) in Millions -8 -9 -8 -19 -20
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to WDDN Management Effectiveness >> WDDN's 5 Years Annual ROE >> Compare WDDN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





WDDN Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions -19 -5 -3 -2 -10
Y / Y Equity Change - - - - -
Net Income in Millions -25 -2 -3 -32 -12
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to WDDN Management Effectiveness >> WDDN's 5 Years Annual ROE >> Compare WDDN ROE to its Competitors




More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
WDDN's' Return on Equity at Yahoo Finance
WDDN's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for WDDN's Competitors
Subscribers only: Roe for Edgemode Inc 's Suppliers
Subscribers only: Return On Equity for WDDN's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Elutia Inc   267.71 %
Cumberland Pharmaceuticals Inc   202.63 %
Alnylam Pharmaceuticals Inc   159.72 %
Amneal Pharmaceuticals Inc   157.05 %
Sanuwave Health Inc   142.86 %
Arbutus Biopharma Corp  129.13 %
Aveanna Healthcare Holdings Inc   115.61 %
Alector Inc   112.21 %
Medpace Holdings Inc   99.76 %
3m Company  93.07 %
Fortress Biotech Inc   88.74 %
Exelixis Inc   85.83 %
Amgen Inc   85.59 %
Meiragtx Holdings Plc  85.25 %
Eli Lilly And Company  83.65 %
Anaptysbio Inc   77.28 %
Rigel Pharmaceuticals Inc  73.94 %
Silexion Therapeutics Corp  71.86 %
Idexx Laboratories Inc  71.18 %
Advanced Biomed Inc.  70.56 %
Elite Pharmaceuticals Inc   59.37 %
Tenet Healthcare Corp  57.13 %
Oramed Pharmaceuticals Inc  52.95 %
Aurinia Pharmaceuticals Inc   51.92 %
Nurix Therapeutics Inc   49.34 %
Carlisle Companies Incorporated  44.18 %
Bristol myers Squibb Company  43.83 %

Date modified: 2026-11-14T05:13:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.